It’s been another fantastic year for the UK DRI, with exciting partnerships, new faces joining the Institute and plenty of important scientific discoveries. Read on to explore some of our highlights from 2023.
Major funding sets us on track for next phase
The year was off to a strong start, with a major funding boost. As a result of a score of ‘excellent’ in our first major review, our principal funder the Medical Research Council (MRC) committed £131 million in funding. This forms part of a collective commitment with our other founding funders, Alzheimer's Society and Alzheimer's Research UK, of £150 million for the next five years. The new funding stands us in great stead to continue to drive forward an ambitious agenda of research, building on our early successes.
Joining forces to accelerate our efforts
We were thrilled to announce a partnership with the British Heart Foundation (BHF), to establish the UK’s first research centre dedicated to vascular dementia. The search for a Director to head up the Centre is now underway. In other news, we joined forces with pharmaceutical company SPARC in a new strategic partnership, and Lilly committed further funds towards our ongoing partnership. Our partnership with LifeArc reached an exciting milestone as £14.5 million was allocated to support seven innovative projects seeking to develop new tests, treatments and medical devices for the more than one million people in the UK living with neurodegenerative conditions.